Welcure Drugs & Pharmaceuticals Limited

WELCURE6

INE331C01017

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:54 2024-05-31 am EDT			5-day change	1st Jan Change
4.75 ^INR	-5.00%		-11.55%	+23.38%

Mar. 22	Welcure Drugs & Pharmaceuticals Limited Announces the Resignation of Priti Rajesh Kharwar as Additional Director, Effective from March 28, 2024	CI
Feb. 16	Welcure Drugs & Pharmaceuticals Appoints Managing Director, CFO	MT

Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Director

August 26, 2022 at 06:34 am EDT

Welcure Drugs & Pharmaceuticals Limited informed that Mr. Mohd Shahbaz Alam (DIN: 06824697) and Mr. Gagan Juneja (DIN: 08914005), Independent Director has resigned from the Board of Directors effective 01 September, 2022.

Latest news about Welcure Drugs & Pharmaceuticals Limited

Welcure Drugs & Pharmaceuticals Limited Announces the Resignation of Priti Rajesh Kharwar as Additional Director, Effective from March 28, 2024	Mar. 22	CI
Welcure Drugs & Pharmaceuticals Appoints Managing Director, CFO	Feb. 15	MT
Welcure Drugs & Pharmaceuticals Limited Announces Board Resignations	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Vishal Mehra as Chief Financial Officer	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mr. Vishal Mehra as Managing Director	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Approves Executive Changes	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Managing Director	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Chief Financial Officer	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Welcure Drugs & Pharmaceuticals Limited Approves the Shifting of the Registered Office	Feb. 14	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 14	CI
Welcure Drugs & Pharmaceuticals Limited Announces Change of Address	Nov. 14	CI
Welcure Drugs & Pharmaceuticals Limited Approves Board Changes	Nov. 14	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mayank Bhandari as Non Executive and Independent Director	23-10-30	CI
Welcure Drugs & Pharmaceuticals Limited Announces Executive Changes	23-09-30	CI
Welcure Drugs & Pharmaceuticals Limited Approves Shifting of Registered Office Within the Local Limits of City of Delhi	23-09-04	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-07-11	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-10-08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mitashi Bisaria as Company Secretary / Compliance Officer, Effective October 8, 2022	22-10-08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Director Resignations, with Effect from October 8, 2022	22-10-08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Sudhir Chandra as Managing Director, with Effect from October 8, 2022	22-10-08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Change in Registered Office Address	22-10-08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Chief Financial Officer Changes	22-09-01	CI
Welcure Drugs & Pharmaceuticals Limited Announces Appointment of Directors	22-09-01	CI

Chart Welcure Drugs & Pharmaceuticals Limited

Duration

Period

Chart Welcure Drugs & Pharmaceuticals Limited

More charts

Company Profile

Welcure Drugs and Pharmaceuticals Limited is an India-based company. The Company is engaged in providing services for procurements of order.

Sector

Pharmaceuticals

Calendar

2024-07-07 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
WELCURE DRUGS & PHARMACEUTICALS LIMITED	+23.38%	769K
CARDINAL HEALTH, INC.	-1.52%	24.18B
SINOPHARM GROUP CO. LTD.	+3.67%	8.46B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+8.55%	8.34B
HUADONG MEDICINE CO., LTD	-23.71%	7.64B
H. LUNDBECK A/S	+15.20%	5.33B
GALENICA AG	+2.68%	4.12B
EBOS GROUP LIMITED	-6.90%	3.92B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+5.56%	3.89B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+18.80%	3.54B